What is Linguaflex?
Linguaflex is a medical device company focused on revolutionizing the treatment of obstructive sleep apnea and snoring through a patent-pending, minimally-invasive device. This discreet and comfortable solution is placed under the tongue during a quick outpatient procedure to maintain an open airway during sleep, thereby enhancing sleep quality. The company is actively collaborating with leading researchers in otolaryngology and sleep medicine to further its technological advancements.
How much funding has Linguaflex raised?
Linguaflex has raised a total of $3.6M across 1 funding round:
Private Equity
$3.6M
Private Equity (2015): $3.6M, investors not publicly disclosed
What's next for Linguaflex?
The substantial enterprise-level funding Linguaflex has garnered, particularly the recent strategic investment, positions the company for significant scaling and market penetration. This capital infusion is expected to accelerate product development, expand clinical trials, and bolster commercialization efforts. The company's focus on a large and underserved market for sleep apnea solutions, combined with its innovative technology, suggests a strong trajectory for future growth and potential for further strategic partnerships or financing rounds.
See full Linguaflex company page
